 |
|
Description of Resource:
The U.S. Preventive Services Task Force recommends against routine use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average risk for breast cancer.
Developed By:
U.S. Preventive Services Task Force
Developer Type:
Federal Government
Healthy People 2020 Topic Area(s):
Cancer
Healthy People 2020 Objectives:
Resource Type:
Citation:
U.S. Preventive Services Task Force. Breast Cancer: Medications for Risk Reduction recommendation statement [Internet]. 2013 Sep [cited 2014 Jan 8]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrpv.htm
Syndicated Content Details:
Source URL: https://www.healthypeople.gov/2020/tools-resources/evidence-based-resource/breast-cancer-medications-for-risk-reduction-clinical Source Agency: Office of Disease Prevention and Health Promotion, Healthy People (ODPHP-HP) Captured Date: 2016-06-09 16:01:45.0
|
|
©2017 ARCHES
Technology. All Rights Reserved.